Is Programmed Death-Ligand 1 of Prognostic Significance in Triple-Negative Female Mammary Carcinoma?

Sanad, Amal Mostafa; Ibrahim, Wael Shawky; Ezzo, Iman Mohamed; Sabry, Rania Mohamed

Sanad, Amal Mostafa; Ibrahim, Wael Shawky; Ezzo, Iman Mohamed; Sabry, Rania Mohamed.

Afiliação

Sanad AM; Department of Pathology, Faculty of Medicine, Tanta Cancer Center, Tanta University, Tanta, Egypt.
Ibrahim WS; Department of Pathology, Faculty of Medicine, Cairo University, Cairo, Egypt.
Ezzo IM; Department of Pathology, Tanta Cancer Center, Tanta University, Tanta, Egypt.
Sabry RM; Department of Pathology, Faculty of Medicine, Cairo University, Cairo, Egypt.

J Microsc Ultrastruct ; 12(1): 6-13, 2024.

Article em En | MEDLINE | ID: mdl-38633572

Palavras-chave

Immunohistochemical; overall survival; prognosis; programmed death-ligand 1; triple-negative breast cancer

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Idioma: En Revista: J Microsc Ultrastruct Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Egito